Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Innovations on multiple sclerosis].

Y Mikaeloff1, H Maurey, M Tardieu

  • 1Service de neurologie pédiatrique et centre de référence sur les maladies inflammatoires du cerveau, Assistance publique-Hôpitaux de Paris, hôpital Bicêtre, Le Kremlin-Bicêtre cedex, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquired cutaneous pseudoxanthoma elasticum progressing after chronic liver transplant rejection.

Annales de dermatologie et de venereologie·2025
Same author

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

French guidelines for the diagnosis and management of MOG antibody-associated disease.

Revue neurologique·2025
Same author

Homocystinuria in a 14-year-old girl with neurodevelopmental delay.

Journal francais d'ophtalmologie·2024
Same author

Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines.

Thrombosis research·2023
Same author

Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective database.

Revue neurologique·2022
Same journal

Family experiences of paediatric palliative care during hospital-at-home: a systematic review.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Knowledge of maternity caregivers on vaccination BCG recommendations and circuits.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

"CRANIOQUALITY study: Quality of life in children with non-syndromic craniosynostosis after surgery".

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Chronological evolution of brain imaging of hemiconvulsion-hemiplegia-epilepsy from 5 cases in Mayotte island.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Point-of-care capillary blood ketone testing to predict the need for intravenous or nasogastric tube rehydration in children with acute gastroenteritis.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Transition practices of patients with inflammatory bowel disease from pediatric to adult healthcare systems. Results from a national survey.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
See all related articles

Pediatric Multiple Sclerosis (MS) understanding has improved with a 7-year French cohort study. Early diagnosis and careful cognitive evaluation are crucial for children with MS.

Area of Science:

  • Neurology
  • Epidemiology
  • Pediatrics

Context:

  • Epidemiological studies, including a 7-year French cohort of nearly 500 children, have enhanced understanding of pediatric Multiple Sclerosis (MS).
  • Pediatric MS can manifest as early as age 2, with distinct symptoms compared to adolescent onset.
  • The progression to motor disability in children is slower than in adults, necessitating careful evaluation of cognitive impairment.

Purpose:

  • To summarize current understanding of pediatric Multiple Sclerosis based on recent epidemiological data.
  • To highlight key differences in symptom presentation and disease progression in pediatric MS.
  • To inform clinical management regarding treatment options and risk factors.

Summary:

  • A French cohort study followed almost 500 children with MS for over 7 years.

Related Experiment Videos

  • Symptoms vary by age, with cognitive impairment being a significant concern.
  • Interferon beta treatment is viable for children under 10, and environmental factors like EBV infection and passive smoking may increase risk.

    • Impact:

    • Improved diagnostic and management strategies for pediatric MS.
    • Increased awareness of cognitive involvement in pediatric MS.
    • Guidance on early treatment initiation and identification of environmental risk factors.